Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells

The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer☆☆☆

(2009) Virginia Tirino et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44

(2009) Shigeo Takaishi et al.   STEM CELLS

CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells

(2008) Naotsugu Haraguchi et al.   ANNALS OF SURGICAL ONCOLOGY

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

(2008) D Horst et al.   BRITISH JOURNAL OF CANCER

The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells

(2008) D. J. Vander Griend et al.   CANCER RESEARCH

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

(2008) L. Du et al.   CLINICAL CANCER RESEARCH

Expression of CD175 (Tn), CD175s (sialosyl-Tn) and CD176 (Thomsen-Friedenreich antigen) on malignant human hematopoietic cells

(2008) Yi Cao et al.   INTERNATIONAL JOURNAL OF CANCER

Characterization of a subpopulation of colon cancer cells with stem cell-like properties

(2008) Peter Chu et al.   INTERNATIONAL JOURNAL OF CANCER

Liver Cancer Stem Cells

(2008) Stewart Sell et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours

(2008) Virginia Tirino et al.   PLoS One

Ovarian cancer: emerging concept on cancer stem cells

(2008) Moorthy P Ponnusamy et al.   Journal of Ovarian Research